Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Interleukin Genetics launches new version of Heart Health Test

This article was originally published in Clinica

Executive Summary

Interleukin Genetics has launched its enhanced Heart Health Genetic Test in the US and Canada. It is an upgrade of the Gensona Heart Health Genetic Test, marketed by Quixtar/Amway, which was launched in 2006. Interleukin developed the diagnostic and licensed it to Quixtar, which prepares the test kit. Interleukin analyses the test and provides its report via its CLIA-registered laboratory. The Waltham, Massachusetts firm explained that the test itself was not new, but it now provides a comprehensive report, which includes quantified risk information on heart attack and coronary artery disease, and more complete information on a person's inflammation-based genetic risk factor for heart attack.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT042334

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel